| Code | Description | Claims | Beneficiaries | Total Paid |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
8,448 |
3,611 |
$913K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,865 |
3,962 |
$490K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,829 |
4,787 |
$445K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,982 |
5,623 |
$406K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
44,182 |
31,642 |
$312K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,664 |
2,915 |
$297K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,782 |
1,508 |
$278K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,844 |
3,437 |
$258K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,602 |
3,026 |
$204K |
| 80053 |
Comprehensive metabolic panel |
25,479 |
19,969 |
$202K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,874 |
1,561 |
$181K |
| 36415 |
Collection of venous blood by venipuncture |
24,280 |
18,419 |
$166K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,393 |
2,006 |
$165K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
19,014 |
16,974 |
$149K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,573 |
2,148 |
$142K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
22,256 |
16,576 |
$130K |
| C1769 |
Guide wire |
1,788 |
1,346 |
$128K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
23,273 |
16,037 |
$115K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,917 |
4,397 |
$111K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,996 |
2,588 |
$110K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,988 |
2,580 |
$108K |
| 83880 |
|
4,420 |
3,543 |
$107K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,560 |
3,599 |
$99K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
769 |
629 |
$95K |
| 84484 |
|
11,781 |
8,344 |
$92K |
| 71046 |
Radiologic examination, chest; 2 views |
6,414 |
5,422 |
$85K |
| 83690 |
|
9,745 |
7,747 |
$84K |
| 81025 |
|
10,838 |
8,820 |
$83K |
| 83735 |
|
9,762 |
6,957 |
$79K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,911 |
3,760 |
$77K |
| 81001 |
|
14,123 |
11,522 |
$72K |
| 59025 |
Fetal non-stress test |
427 |
341 |
$71K |
| 29581 |
|
1,904 |
643 |
$70K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,596 |
5,704 |
$68K |
| 71045 |
Radiologic examination, chest; single view |
10,540 |
8,241 |
$67K |
| 86901 |
|
4,584 |
3,507 |
$63K |
| 80047 |
|
6,468 |
4,634 |
$61K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
721 |
588 |
$61K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,456 |
4,742 |
$60K |
| 82962 |
|
14,007 |
7,328 |
$60K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,815 |
5,334 |
$54K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,845 |
1,420 |
$47K |
| 83605 |
|
3,937 |
3,018 |
$46K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
673 |
485 |
$45K |
| T1015 |
Clinic visit/encounter, all-inclusive |
3,915 |
3,433 |
$42K |
| 80061 |
Lipid panel |
3,369 |
2,829 |
$42K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,542 |
6,592 |
$41K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,735 |
2,085 |
$39K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,199 |
891 |
$36K |
| 93296 |
|
4,422 |
4,158 |
$35K |
| 87077 |
|
3,701 |
2,958 |
$35K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
21,419 |
12,263 |
$33K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
10,045 |
6,189 |
$33K |
| 81003 |
|
9,443 |
7,693 |
$32K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
387 |
206 |
$32K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,104 |
4,251 |
$32K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,722 |
1,810 |
$31K |
| 85610 |
|
14,629 |
11,002 |
$31K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,204 |
3,594 |
$30K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
170 |
129 |
$29K |
| 82550 |
|
2,655 |
2,050 |
$27K |
| 80076 |
|
2,794 |
2,224 |
$27K |
| 73564 |
|
913 |
721 |
$25K |
| 87070 |
|
2,287 |
1,737 |
$25K |
| 80320 |
|
2,049 |
1,772 |
$24K |
| 85730 |
|
7,422 |
5,764 |
$23K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
125 |
108 |
$22K |
| 86850 |
|
3,967 |
2,974 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,522 |
1,052 |
$21K |
| 87040 |
|
3,114 |
1,429 |
$21K |
| 82565 |
|
1,713 |
1,297 |
$19K |
| 72131 |
|
212 |
179 |
$19K |
| 36430 |
|
282 |
199 |
$18K |
| 80050 |
General health panel |
389 |
367 |
$17K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,974 |
887 |
$17K |
| 85379 |
|
2,272 |
1,918 |
$17K |
| 93458 |
|
585 |
459 |
$17K |
| 96376 |
|
2,777 |
1,505 |
$15K |
| 84145 |
|
1,269 |
1,013 |
$15K |
| 87430 |
|
1,380 |
1,172 |
$14K |
| 85027 |
|
2,852 |
2,087 |
$12K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
400 |
261 |
$12K |
| 86900 |
|
4,584 |
3,506 |
$12K |
| 82553 |
|
1,725 |
1,318 |
$11K |
| 87210 |
|
2,808 |
2,283 |
$11K |
| 93017 |
|
1,950 |
1,628 |
$11K |
| 73030 |
|
558 |
446 |
$11K |
| 87081 |
|
1,631 |
1,374 |
$11K |
| 87186 |
|
2,881 |
2,305 |
$10K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,882 |
3,735 |
$10K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
72 |
63 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
794 |
743 |
$10K |
| 71250 |
|
126 |
101 |
$9K |
| 84702 |
|
967 |
829 |
$9K |
| 80074 |
|
264 |
237 |
$9K |
| 85014 |
|
8,346 |
5,843 |
$9K |
| 73630 |
|
328 |
276 |
$8K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
988 |
438 |
$8K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
702 |
556 |
$8K |
| 76801 |
|
242 |
219 |
$8K |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
554 |
441 |
$7K |
| 87205 |
|
2,868 |
2,009 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,919 |
5,742 |
$7K |
| 80329 |
|
741 |
672 |
$7K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
6,773 |
3,713 |
$6K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
32 |
25 |
$6K |
| 90715 |
|
327 |
281 |
$6K |
| 73610 |
|
279 |
245 |
$5K |
| 70486 |
|
43 |
38 |
$5K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,323 |
1,142 |
$5K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
216 |
155 |
$5K |
| 86703 |
|
401 |
368 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
646 |
525 |
$5K |
| 84703 |
|
561 |
429 |
$5K |
| 84439 |
|
995 |
907 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
9,619 |
6,890 |
$4K |
| 82607 |
|
482 |
449 |
$4K |
| 93880 |
|
230 |
210 |
$3K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,575 |
1,321 |
$3K |
| 86780 |
|
232 |
220 |
$3K |
| 70496 |
|
46 |
38 |
$3K |
| 70498 |
|
39 |
36 |
$3K |
| 72110 |
|
107 |
95 |
$3K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
4,218 |
2,984 |
$3K |
| A9270 |
Non-covered item or service |
17,275 |
9,226 |
$3K |
| 72141 |
|
15 |
14 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
13,041 |
8,779 |
$3K |
| 84132 |
|
1,447 |
1,054 |
$3K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
110 |
31 |
$3K |
| 84481 |
|
395 |
369 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
7,270 |
4,161 |
$3K |
| J1750 |
Injection, iron dextran, 50 mg |
18 |
12 |
$3K |
| 88342 |
|
220 |
168 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,123 |
521 |
$2K |
| 84100 |
|
809 |
547 |
$2K |
| 82947 |
|
1,242 |
914 |
$2K |
| 93280 |
|
810 |
767 |
$2K |
| J1815 |
Injection, insulin, per 5 units |
756 |
402 |
$2K |
| 85049 |
|
627 |
427 |
$2K |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
127 |
92 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
52 |
42 |
$2K |
| 97162 |
|
124 |
109 |
$2K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
182 |
146 |
$2K |
| 73130 |
|
80 |
68 |
$2K |
| 76937 |
|
620 |
484 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,955 |
1,381 |
$2K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,065 |
709 |
$2K |
| 11045 |
|
238 |
103 |
$2K |
| 74018 |
|
180 |
144 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
2,113 |
1,691 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,100 |
1,384 |
$1K |
| 82803 |
|
74 |
54 |
$1K |
| J1644 |
Injection, heparin sodium, per 1000 units |
5,974 |
3,052 |
$1K |
| 82746 |
|
167 |
155 |
$1K |
| 96367 |
|
32 |
12 |
$1K |
| 87428 |
|
42 |
39 |
$1K |
| 72100 |
|
95 |
54 |
$1K |
| 73502 |
|
62 |
50 |
$1K |
| 78803 |
|
14 |
12 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
378 |
155 |
$965.07 |
| 85045 |
|
459 |
258 |
$964.60 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
7,390 |
4,848 |
$954.42 |
| 83525 |
|
84 |
76 |
$874.96 |
| 97597 |
|
92 |
71 |
$839.34 |
| 82010 |
|
16 |
13 |
$832.89 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
7,888 |
4,504 |
$832.77 |
| 93971 |
|
55 |
50 |
$829.92 |
| J2704 |
Injection, propofol, 10 mg |
5,014 |
3,345 |
$828.36 |
| 83550 |
|
177 |
165 |
$754.42 |
| 83540 |
|
251 |
229 |
$753.71 |
| 86923 |
|
269 |
199 |
$746.64 |
| 93970 |
|
50 |
39 |
$728.89 |
| J1630 |
Injection, haloperidol, up to 5 mg |
512 |
414 |
$696.52 |
| 82728 |
|
76 |
69 |
$633.54 |
| 78306 |
|
13 |
12 |
$584.52 |
| 36600 |
|
37 |
26 |
$562.96 |
| J1956 |
Injection, levofloxacin, 250 mg |
649 |
469 |
$552.56 |
| 97001 |
|
60 |
41 |
$494.40 |
| 88304 |
|
19 |
13 |
$484.58 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
32 |
27 |
$481.47 |
| 85651 |
|
212 |
196 |
$466.03 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,708 |
1,294 |
$465.99 |
| J3480 |
Injection, potassium chloride, per 2 meq |
484 |
180 |
$409.95 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,611 |
1,245 |
$346.83 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
6,585 |
5,220 |
$309.94 |
| 85347 |
|
338 |
169 |
$306.87 |
| 87340 |
|
28 |
24 |
$298.98 |
| 90686 |
|
57 |
46 |
$283.10 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
15 |
12 |
$275.18 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
2,362 |
1,729 |
$267.31 |
| 94729 |
|
18 |
14 |
$241.00 |
| 87075 |
|
94 |
71 |
$236.56 |
| 76376 |
|
30 |
25 |
$229.04 |
| 94726 |
|
18 |
14 |
$221.10 |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
26 |
25 |
$205.94 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
255 |
155 |
$203.14 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,484 |
1,139 |
$201.65 |
| 93321 |
|
94 |
75 |
$200.26 |
| 82270 |
|
23 |
20 |
$184.40 |
| 82951 |
|
14 |
12 |
$183.90 |
| 82043 |
|
87 |
85 |
$181.16 |
| 84480 |
|
43 |
38 |
$162.00 |
| 87045 |
|
13 |
13 |
$148.17 |
| 84550 |
|
69 |
66 |
$141.24 |
| 81015 |
|
372 |
332 |
$138.61 |
| 93356 |
|
68 |
55 |
$137.73 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15 |
13 |
$135.69 |
| 93325 |
|
136 |
106 |
$132.32 |
| 76000 |
|
251 |
194 |
$129.47 |
| 93290 |
|
12 |
12 |
$115.24 |
| J1790 |
Injection, droperidol, up to 5 mg |
648 |
482 |
$113.91 |
| 82570 |
|
51 |
49 |
$103.46 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
31 |
31 |
$100.68 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
752 |
559 |
$95.46 |
| 87102 |
|
51 |
42 |
$87.24 |
| J1940 |
Injection, furosemide, up to 20 mg |
1,323 |
816 |
$86.80 |
| 87116 |
|
16 |
13 |
$81.32 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
454 |
349 |
$54.40 |
| 93283 |
|
42 |
40 |
$46.43 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
322 |
180 |
$40.79 |
| 87206 |
|
15 |
13 |
$40.42 |
| 87046 |
|
13 |
13 |
$37.07 |
| 86140 |
|
12 |
12 |
$29.56 |
| 76942 |
|
30 |
27 |
$16.75 |
| G0378 |
Hospital observation service, per hour |
2,427 |
1,779 |
$7.91 |
| 89051 |
|
17 |
13 |
$7.86 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
101 |
69 |
$4.38 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
135 |
70 |
$0.92 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
104 |
88 |
$0.01 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
103 |
87 |
$0.01 |
| 36416 |
|
122 |
110 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
61 |
40 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
57 |
41 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
104 |
90 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
412 |
255 |
$0.00 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
19 |
12 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
198 |
168 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
43 |
39 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
70 |
47 |
$0.00 |